Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis

Journal of Rheumatology

Volumn 29, Issue 9, 2002, Pages 1877-1883

  Kawaguchi, Yasushi ^a   Harigai, Masayoshi ^a   Hara, Masako ^a   Fukasawa, Chikako ^a   Takagi, Kae ^a   Tanaka, Michi ^a   Tanaka, Eiichi ^a   Nishimagi, Emi ^a   Kamatani, Naoyuki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

C met; Fibroblasts; Fibrosis; Hepatocyte growth factor; Systemic sclerosis

Indexed keywords

C PEPTIDE; COLLAGEN TYPE 1; COMPLEMENTARY DNA; INTERLEUKIN 1ALPHA; MESSENGER RNA; POLYCLONAL ANTIBODY; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ADULT; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; FEEDBACK SYSTEM; FEMALE; FIBROSIS; GENE EXPRESSION; GENE INDUCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; SYSTEMIC SCLEROSIS;

ADULT; AUTOANTIBODIES; BASE SEQUENCE; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROBABILITY; PROTO-ONCOGENE PROTEINS C-MET; RNA, MESSENGER; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SKIN; STATISTICS, NONPARAMETRIC;

EID: 0036731985     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Systemic sclerosis (scleroderma): Clinical aspects
2. Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma)
3. Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts
4. Heterogenous synthetic phenotype of cloned scleroderma fibroblasts may be due to aberrant regulation in the synthesis of connective tissue
5. Selective upregulation of platelet-derived growth factor α receptors by transforming growth factor β in scleroderma fibroblasts
6. Increased collagen synthesis by scleroderma skin fibroblasts in vitro. A possible defect in the regulation or activation of the scleroderma fibroblasts
7. Co-localization of transforming growth factor β2 with α1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis
8. Endogenous IL-1a from systemic sclerosis fibroblasts induces IL-6 and PDGF-A
9. Blockade of endogenous transforming growth factor B signaling prevents upregulated collagen synthesis in scleroderma fibroblasts: Association with increased expression of transforming growth factor β receptors
10. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling
11. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures
12. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo
13. Differential regulation of keratinocyte growth factor and hepatocyte growth factor/scatter factor by different cytokines in human corneal and limbal fibroblasts
14. Hepatocyte growth factor is a potent mitogen for cultured rabbit renal tubular epithelial cells
15. Hepatocyte growth factor. A cytokine mediating endothelial migration in inflammatory arthritis
16. Hepatocyte growth factor: Mitogen, motogen, and morphogen
17. Increased levels of hepatocyte growth factor in sera of patients with systemic sclerosis
18. Prediction of outcome in fulminant hepatic failure by serum human hepatocyte growth factor
19. Hepatocyte growth factor and neutrophil elastase in idiopathic pulmonary fibrosis
20. Serum HGF levels in acute renal rejection after living related renal transplantation
21. Identification of the hepatocyte growth factor as the c-met proto-oncogene product
22. Analysis by pulsed field gel electrophoresis reveals complex rearrangements in two MET alleles in a chemically-treated human cell line, MNNG-HOS
23. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
24. Scleroderma (systemic sclerosis): Classification subsets and pathogenesis
25. IL-1α gene expression and protein production by fibroblasts from patients with systemic sclerosis
26. Lipofection: A highly efficient, lipid-mediated DNA/transfection procedure
27. Interleukin 1 induces an autocrine loop hepatocyte growth factor/c-Met in murine Kaposi-like spindle cells
28. Emerging multipotent aspects of hepatocyte growth factor
29. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages
30. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization
31. Induction of hepatocyte growth factor in human skin fibroblasts by epidermal growth factor, platelet-derived growth factor and fibroblast growth factor
32. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis
33. Simultaneous or delayed administration of hepatocyte growth factor (HGF) equally repress the fibrotic changes in murine lung injury by bleomycin: A morphological study
34. Hepatocyte growth factor prevents renal fibrosis and dysfunction in mouse model of chronic renal disease
35. Expression of hepatocyte growth factor/scatter factor and c-Met in human dental papilla and fibroblasts from dental papilla
36. Myocardial protection from ischerma/reperfusion injury by endogenous and exogenous HGF